search for books and compare prices
By
Ralph Villiger and
Boris Bogdan
Price
Store
Arrives
Preparing
Shipping
Jump quickly to results on these stores:
The price is the lowest for any condition, which may be new or used; other conditions may also be available.
Bibliographic Detail
Publisher
Springer Verlag
Publication date
May 6, 2010
Pages
370
Binding
Hardcover
Edition
3
Book category
Adult Non-Fiction
ISBN-13
9783642108198
ISBN-10
3642108199
Dimensions
1.25 by 6.50 by 9.75 in.
Weight
1.55 lbs.
Published in
Europe
Original list price
$89.99
Amazon.com says people who bought this book also bought:
The BioTech Primer | Pharmaceutical Lifecycle Management | Business Development for the Biotechnology and Pharmaceutical Industry | Forecasting for the Pharmaceutical Industry | The Biotech Investor's Bible | Biotechnology Valuation | New Drugs | The Billion-Dollar Molecule | The Strategic Pricing of Pharmaceuticals
The BioTech Primer | Pharmaceutical Lifecycle Management | Business Development for the Biotechnology and Pharmaceutical Industry | Forecasting for the Pharmaceutical Industry | The Biotech Investor's Bible | Biotechnology Valuation | New Drugs | The Billion-Dollar Molecule | The Strategic Pricing of Pharmaceuticals
Summaries and Reviews
Amazon.com description: Product Description: Valuation is a hot topic among life sciences professionals. There is no clear understanding on how to use the different valuation approaches and how to determine input parameters. Some do not value at all, arguing that it is not possible to get realistic and objective numbers out of it. Some claim it to be an art. In the following chapters we will provide the user with a concise val- tion manual, providing transparency and practical insight for all dealing with valuation in life sciences: project and portfolio managers, licensing executives, business developers, technology transfer managers, entrep- neurs, investors, and analysts. The purpose of the book is to explain how to apply discounted cash flow and real options valuation to life sciences p- jects, i.e. to license contracts, patents, and firms. We explain the fun- mentals and the pitfalls with case studies so that the reader is capable of performing the valuations on his own and repeat the theory in the exercises and case studies. The book is structured in five parts: In the first part, the introduction, we discuss the role of the players in the life sciences industry and their p- ticular interests. We describe why valuation is important to them, where they need it, and the current problems to it. The second part deals with the input parameters required for valuation in life sciences, i.e. success rates, costs, peak sales, and timelines.
Pricing is shown for items sent to or within the U.S., excluding shipping and tax. Please consult the store to determine exact fees. No warranties are made express or implied about the accuracy, timeliness, merit, or value of the information provided. Information subject to change without notice. isbn.nu is not a bookseller, just an information source.